Bionik Laboratories Corp. (BNKL)
Bionik Laboratories Corp. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Watertown, MA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,248. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -274.0%. Its beta of 9.36 implies it has historically moved more than the broad market.
Bionik Laboratories Corp. operates as a robotics firm, focusing on the innovation, development, and market introduction of advanced solutions for physical rehabilitation, prosthetic devices, and assistive robotics. The company's product range features the InMotion Robots, a comprehensive collection of robotic therapy tools. This includes the InMotion ARM, an intelligent and interactive therapeutic system grounded in scientific evidence, adept at perceiving patient movements and physical restrictions. Additionally, the InMotion ARM/HAND is offered to facilitate therapies requiring reaching with grasping and releasing actions, alongside individual hand manipulations. Rounding out their offerings is the InMotion Connect platform, which integrates a hardware unit that interfaces with an InMotion Robot, coupled with a subscription for the InMotion Connect Pulse service. Established in 2010, Bionik Laboratories Corp. maintains its principal operations in Watertown, Massachusetts.
Bionik Laboratories Corp. is most often compared with the following Healthcare names: